Article
NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review.
PloS one - 1 Jan 2023
Gutiérrez-Virgen Jorge E, Piña-Pozas Maricela, Hernández-Tobías Esther A, Taja-Chayeb Lucia, López-González Ma de Lourdes, Meraz-Ríos Marco A, Gómez Rocío
Abstract excerpt
Arylamine N-acetyltransferase 2 has been related to drug side effects and cancer susceptibility; its protein structure and acetylation capacity results from the polymorphism's arrays on the NAT2 gene. Absorption, distribution, metabolism, and excretion, cornerstones of the pharmacological effects, have shown diversity patterns across populations, ethnic groups, and even interethnic variation. Although the 1000...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
